Trevor R.F. Smith

2.3k total citations
32 papers, 506 citations indexed

About

Trevor R.F. Smith is a scholar working on Immunology, Infectious Diseases and Biotechnology. According to data from OpenAlex, Trevor R.F. Smith has authored 32 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 11 papers in Infectious Diseases and 10 papers in Biotechnology. Recurrent topics in Trevor R.F. Smith's work include Immunotherapy and Immune Responses (10 papers), Microbial Inactivation Methods (9 papers) and Virus-based gene therapy research (7 papers). Trevor R.F. Smith is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Microbial Inactivation Methods (9 papers) and Virus-based gene therapy research (7 papers). Trevor R.F. Smith collaborates with scholars based in United States, Australia and Canada. Trevor R.F. Smith's co-authors include Kate E. Broderick, Katherine Schultheis, Niranjan Y. Sardesai, Vipin Kumar, Janess Mendoza, Dinah Amante, Laurent Humeau, David B. Weiner, Kar Muthumani and Ami Patel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Trevor R.F. Smith

31 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trevor R.F. Smith United States 13 196 194 164 87 78 32 506
J. Joseph Kim United States 11 222 1.1× 263 1.4× 168 1.0× 179 2.1× 73 0.9× 13 635
Janess Mendoza United States 11 94 0.5× 120 0.6× 110 0.7× 65 0.7× 102 1.3× 12 338
Thy T. Follmer United States 3 113 0.6× 161 0.8× 218 1.3× 57 0.7× 53 0.7× 6 384
Frances E. Pearson Australia 13 73 0.4× 343 1.8× 125 0.8× 40 0.5× 46 0.6× 16 560
Lukkana Suksanpaisan United States 16 252 1.3× 104 0.5× 186 1.1× 108 1.2× 37 0.5× 34 724
Leopold Grillberger Austria 9 165 0.8× 179 0.9× 115 0.7× 161 1.9× 32 0.4× 12 474
Clare Primiero Australia 11 47 0.2× 136 0.7× 94 0.6× 74 0.9× 36 0.5× 32 540
Sudhirdas Prayaga United States 4 60 0.3× 204 1.1× 179 1.1× 91 1.0× 22 0.3× 5 389
Yunzhang Hu China 16 185 0.9× 145 0.7× 310 1.9× 73 0.8× 13 0.2× 45 592

Countries citing papers authored by Trevor R.F. Smith

Since Specialization
Citations

This map shows the geographic impact of Trevor R.F. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trevor R.F. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trevor R.F. Smith more than expected).

Fields of papers citing papers by Trevor R.F. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trevor R.F. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trevor R.F. Smith. The network helps show where Trevor R.F. Smith may publish in the future.

Co-authorship network of co-authors of Trevor R.F. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Trevor R.F. Smith. A scholar is included among the top collaborators of Trevor R.F. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trevor R.F. Smith. Trevor R.F. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Yunyi, et al.. (2024). Transforming tumor immune microenvironments with a novel systemic enveloped oncolytic virotherapy targeting all tumor sites.. Journal of Clinical Oncology. 42(16_suppl). 2559–2559.
2.
Andrade, Viviane M., et al.. (2023). Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models. Human Vaccines & Immunotherapeutics. 19(3). 2281733–2281733. 5 indexed citations
3.
Park, Daniel H., Kevin Liaw, Pratik Bhojnagarwala, et al.. (2023). Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape. Molecular Therapy — Oncolytics. 28. 249–263. 11 indexed citations
4.
Tursi, Nicholas J., Ziyang Xu, Susanne N. Walker, et al.. (2023). Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo. Frontiers in Immunology. 14. 1072810–1072810. 3 indexed citations
5.
Cusimano, Gina, E. Gary, Matthew R. Bell, et al.. (2022). Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1. The Journal of Immunology. 209(1). 118–127. 3 indexed citations
6.
Gary, E., Nicholas J. Tursi, Bryce M. Warner, et al.. (2022). Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivo. Cell Reports Medicine. 3(7). 100693–100693. 10 indexed citations
7.
Riddell, Shane, Sarah Goldie, Alexander J. McAuley, et al.. (2021). Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets. Frontiers in Immunology. 12. 694857–694857. 6 indexed citations
8.
Walker, Susanne N., Neethu Chokkalingam, Emma L. Reuschel, et al.. (2020). SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients. Journal of Clinical Microbiology. 58(11). 42 indexed citations
9.
Thorne, Amy Haseley, Tricia T Nguyen, Neil Cooch, et al.. (2020). Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell Responses. Frontiers in Immunology. 11. 327–327. 10 indexed citations
10.
McAuley, Alexander J., Michael J. Kuiper, Peter A. Durr, et al.. (2020). Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein. npj Vaccines. 5(1). 96–96. 40 indexed citations
11.
Schultheis, Katherine, Holly Pugh, Bryan S. Yung, et al.. (2019). Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination. Journal of Visualized Experiments. 2 indexed citations
12.
Yung, Bryan S., Katherine Schultheis, Kar Muthumani, et al.. (2019). Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation. Human Gene Therapy. 30(4). 523–533. 8 indexed citations
13.
Yung, Bryan S., Holly Pugh, Alison Generotti, et al.. (2019). Novel IFN-γ ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits. Vaccine. 37(7). 903–909. 3 indexed citations
14.
Duperret, Elizabeth K., Regina Stoltz, Ami Patel, et al.. (2018). Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti–CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo. Cancer Research. 78(22). 6363–6370. 49 indexed citations
15.
Schultheis, Katherine, et al.. (2018). Delineating the Cellular Mechanisms Associated with Skin Electroporation. Human Gene Therapy Methods. 29(4). 177–188. 24 indexed citations
16.
Fisher, Paul D., William B. Kiosses, Janess Mendoza, et al.. (2017). Adipose tissue: a new target for electroporation-enhanced DNA vaccines. Gene Therapy. 24(12). 757–767. 13 indexed citations
17.
Schultheis, Katherine, Bryan S. Yung, Kar Muthumani, et al.. (2016). Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin. Vaccine. 35(1). 61–70. 13 indexed citations
18.
Smith, Trevor R.F., Katherine Schultheis, William B. Kiosses, et al.. (2014). DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response. Molecular Therapy — Methods & Clinical Development. 1. 14054–14054. 25 indexed citations
19.
Kichaev, Gleb, Janess Mendoza, Dinah Amante, et al.. (2013). Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses. Human Vaccines & Immunotherapeutics. 9(10). 2041–2048. 33 indexed citations
20.
Smith, Trevor R.F., et al.. (1971). Effects of tumor viruses on cellular growth and transformation.. PubMed. 56(9). 367–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Joseph Kim Breakdown of academic impact, for papers by Janess Mendoza Breakdown of academic impact, for papers by Thy T. Follmer Breakdown of academic impact, for papers by Frances E. Pearson Breakdown of academic impact, for papers by Lukkana Suksanpaisan Breakdown of academic impact, for papers by Leopold Grillberger Breakdown of academic impact, for papers by Clare Primiero Breakdown of academic impact, for papers by Sudhirdas Prayaga Breakdown of academic impact, for papers by Yunzhang Hu
Rankless by CCL
2026